Association of leptin with insulin resistance, body composition, and lipid parameters in postmenopausal women and men in type 2 diabetes mellitus

Saudi Medical Journal

Volumn 29, Issue 6, 2008, Pages 813-820

  Gulturk, Sefa ^a   Cetin, Ali ^a   Erdal, Sena ^a  

^a CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLIPIZIDE; LEPTIN; METFORMIN; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; BASAL METABOLIC RATE; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WATER; BODY WEIGHT; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN RESISTANCE; INTERMETHOD COMPARISON; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

ADIPOSE TISSUE; ADULT; AGED; BODY COMPOSITION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; POSTMENOPAUSE;

EID: 49149116445     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Arner P. Insulin resistance in type 2 diabetes - role of the adipokines. Curr Mol Med 2005; 5: 333-339.
2. Daghestani MH, Ozand PT, Al-Himadi AR, Al-Odaib AN. Hormonal levels of leptin, insulin, ghrelin, and neuropeptide y in lean, overweight, and obese Saudi females. Saudi Med J 2007; 28: 1191-1197.
3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
4. Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgau MM, Vinicor F, et al. Diabetes trends in the US: 1990-1998. Diabetes Care 2000; 23: 1278-1283.
5. Sharma AM, Chetty VT. Obesity, hypertension and insulin resistance. Acta Diabetol 2005; 42 Suppl 1: S3-S8.
6. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balancec overview. Diabetes Care 1992; 15: 318-368.
7. Poehlman ET, Toth MJ, Gardner AW. Changes in energy balance and body composition at menopause: A controlled longitudinal study. Ann Intern Med 1995; 123: 673-675.
8. Chu MC, Cosper P, Orio F, Carmina E, Lobo RA. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin. Am J Obstet Gynecol 2006; 194: 100-104.
9. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006; 29 Suppl 1: S43-S48.
10. Yamamoto R, Kimura S, Hattori S, Matsuura A, Hayakawa T. Immunoenzymometric assay for insulin involving column chromatography and insulin immobilized on Sepharose. Clin Chem 1985; 31: 628-630.
11. Garber CC, Feldbruegge D, Miller RC, Carey RN. Evaluation of the co-immobilized hexokinase/glucose-6-phosphate dehydrogenase method for glucose, as adapted to the technicon smac. Clin Chem 1978; 24: 1186-1190.
12. Brozek J, Grande F, Anderson JT, Keys A. Densitometric analysis of body composition: Revision of some quantitative assumptions. Ann N Y Acad Sci 1963; 110: 113-140.
13. Kotler DP, Burastero S, Wang J, Pierson RN Jr. Prediction of body cell mass, fat-free mass, and total body water with bioelectrical impedance analysis: Effects of race, sex, and disease. Am J Clin Nutr 1996; 64 Suppl 3: S489-S497.
14. Tzotzas T, Krassas GE, Doumas A. Body composition analysis in obesity: Radionuclide and non radionuclide methods. Hell J Nucl Med 2008; 11: 63-71.
15. Stolarcyk LM, Heyward VH. Assessing body composition of adults with diabetes. Diabetes Technol Ther 1999; 1: 289-296.
16. Hergenc G, Onat A, Sari I, Yazici M, Eryonucu B, Can G. Serum total and high-density lipoprotein phospholipid levels in a population-based study and relationship to risk of metabolic syndrome and coronary disease. Angiology 2008; 59: 26-35.
17. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763-770.
18. Abdelgadir M, Elbagir M, Eltom M, Berne C, Ahren B. Reduced leptin concentrations in subjects with type 2 diabetes mellitus in Sudan. Metabolism 2002; 51:304-306.
19. Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, et al. The metabolic significance of leptin in humans: Gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 1997; 82: 1293-1300.
20. Appleton DJ, Rand JS, Sunvold GD. Plasma leptin concentrations are independently associated with insulin sensitivity in lean and overweight cats. J Feline Med Surg 2002; 4: 83-93.
21. Kong AP, Chan NN, Chan JC. The role of adipocytokines and neurohormonal dysregulation in metabolic syndrome. Curr Diabetes Rev 2006; 2: 397-407.
22. Paolisso G, Rizzo MR, Mazziotti G, Rotondi M, Tagliamonte MR, Varricchio G, et al. Lack of association between changes in plasma leptin concentration and in food intake during the menstrual cycle. Eur J Clin Invest 1999; 29: 490-495.
23. Stern SE, Williams K, Ferrannini E, DeFronzo RA, Bogardus C, Stern MP. Identification of individuals with insulin resistance using routine clinical measurements. Diabetes 2005; 54: 333-339.
24. Garg A. Lipid-lowering therapy and macrovascular disease in diabetes mellitus. Diabetes 1992; 41 Suppl 2: S111-S115.
25. Laakso M, Barrett-Connor E. Asymptomatic hyperglycemia is associated with lipid and lipoprotein changes favoring atherosclerosis. Arteriosclerosis 1989; 9: 665-672.
26. Aghaeishahsavari M, Noroorzianavval M, Veisi P, Parizad R, Samadikhah J. Cardiovascular disease risk factors in patients with confirmed cardiovascular disease. Saudi Med J 2006; 27: 1358-1361.
27. Heilbronn LK, Civitarese AE, Bogacka I, Smith SR, Hulver M, Ravussin E. Glucose tolerance and skeletal muscle gene expression in response to alternate day fasting. Obes Res 2005; 13: 574-581.
28. O'Brien T, Nguyen TT, Zimmerman BR. Hyperlipidemia and diabetes mellitus. Mayo Clin Proc 1998; 73: 969-976.
29. Nandeesha H, Koner BC, Dorairajan LN. Altered insulin sensitivity, insulin secretion and lipid profile in non-diabetic prostate carcinoma. Acta Physiol Hung 2008; 95: 97-105.
30. Lomtadze I, Virsaladze D, Koplatadze M, Mikashavidze T. The relation of insulin resistance with the complications of diabetes mellitus type 2 and metabolic parameters. Georgian Med News 2008; 154: 26-29.